Humana AB Valuation
| HUM Stock | SEK 36.70 0.20 0.55% |
At this time, the firm appears to be fairly valued. Humana AB retains a regular Real Value of kr36.66 per share. The prevalent price of the firm is kr36.7. Our model calculates the value of Humana AB from evaluating the firm fundamentals such as Return On Equity of 0.0794, current valuation of 6.55 B, and Return On Asset of 0.0292 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Humana AB's price fluctuation is very steady at this time. Calculation of the real value of Humana AB is based on 3 months time horizon. Increasing Humana AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Humana AB's intrinsic value may or may not be the same as its current market price of 36.70, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.7 | Real 36.66 | Hype 36.7 | Naive 37.64 |
The intrinsic value of Humana AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Humana AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Humana AB helps investors to forecast how Humana stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humana AB more accurately as focusing exclusively on Humana AB's fundamentals will not take into account other important factors: Humana AB Total Value Analysis
Humana AB is currently expected to have takeover price of 6.55 B with market capitalization of 735.56 M, debt of 4.7 B, and cash on hands of 695 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Humana AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.55 B | 735.56 M | 4.7 B | 695 M |
Humana AB Investor Information
About 72.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Humana AB recorded earning per share (EPS) of 6.27. The entity last dividend was issued on the 10th of May 2019. Based on the measurements of operating efficiency obtained from Humana AB's historical financial statements, Humana AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Humana AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Humana AB has an asset utilization ratio of 90.95 percent. This implies that the Company is making kr0.91 for each dollar of assets. An increasing asset utilization means that Humana AB is more efficient with each dollar of assets it utilizes for everyday operations.Humana AB Ownership Allocation
Humana AB has a total of 47.83 Million outstanding shares. The majority of Humana AB outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Humana AB to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Humana AB. Please pay attention to any change in the institutional holdings of Humana AB as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Humana AB Profitability Analysis
The company reported the revenue of 8.19 B. Net Income was 354 M with profit before overhead, payroll, taxes, and interest of 1.99 B.About Humana AB Valuation
The stock valuation mechanism determines Humana AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Humana AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Humana AB. We calculate exposure to Humana AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Humana AB's related companies.Humana AB , together with its subsidiaries, provides individual and family care services for children, adolescents, and adults in Sweden, Norway, Denmark, and Finland. Humana AB was founded in 2001 and is headquartered in Stockholm, Sweden. Humana AB operates under Personal Services classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11238 people.
8 Steps to conduct Humana AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Humana AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Humana AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Humana AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Humana AB's revenue streams: Identify Humana AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Humana AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Humana AB's growth potential: Evaluate Humana AB's management, business model, and growth potential.
- Determine Humana AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Humana AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Humana Stock Analysis
When running Humana AB's price analysis, check to measure Humana AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana AB is operating at the current time. Most of Humana AB's value examination focuses on studying past and present price action to predict the probability of Humana AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana AB's price. Additionally, you may evaluate how the addition of Humana AB to your portfolios can decrease your overall portfolio volatility.